keyword
https://read.qxmd.com/read/38700031/novel-catechol-o-methyltransferases-from-lentinula-edodes-catalyze-the-generation-of-taste-active-flavonoids
#1
JOURNAL ARTICLE
Jean-Philippe Kanter, Lars Milke, Judith K Metz, Ali Biabani, Hartmut Schlüter, Martin Gand, Jakob P Ley, Holger Zorn
Due to the increasing demand for natural food ingredients, including taste-active compounds, enzyme-catalyzed conversions of natural substrates, such as flavonoids, are promising tools to align with the principles of Green Chemistry. In this study, a novel O -methyltransferase activity was identified in the mycelium of Lentinula edodes , which was successfully applied to generate the taste-active flavonoids hesperetin, hesperetin dihydrochalcone, homoeriodictyol, and homoeriodictyol dihydrochalcone. Furthermore, the mycelium-mediated OMT activity allowed for the conversion of various catecholic substrates, yielding their respective (iso-)vanilloids, while monohydroxylated compounds were not converted...
May 3, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38689006/longitudinal-study-investigating-the-influence-of-comt-gene-polymorphism-on-cortical-thickness-changes-in-parkinson-s-disease-over-four-years
#2
JOURNAL ARTICLE
Amin Tajerian
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting over 3% of those over 65. It's caused by reduced dopaminergic neurons and Lewy bodies, leading to motor and non-motor symptoms. The relationship between COMT gene polymorphisms and PD is complex and not fully elucidated. Some studies have reported associations between certain COMT gene variants and PD risk, while others have not found significant associations. This study investigates how COMT gene variations impact cortical thickness changes in PD patients over time, aiming to link genetic factors, especially COMT gene variations, with PD progression...
April 30, 2024: Scientific Reports
https://read.qxmd.com/read/38684743/network-pharmacology-combined-with-molecular-docking-and-experimental-verification-to-elucidate-the-effect-of-flavan-3-ols-and-aromatic-resin-on-anxiety
#3
JOURNAL ARTICLE
Ansari Vikhar Danish Ahmad, Subur W Khan, Syed Ayaz Ali, Qazi Yasar
This study investigated the potential anxiolytic properties of flavan-3-ols and aromatic resins through a combined computational and experimental approach. Network pharmacology techniques were utilized to identify potential anxiolytic targets and compounds by analyzing protein-protein interactions and KEGG pathway data. Molecular docking and simulation studies were conducted to evaluate the binding interactions and stability of the identified targets. Behavioral tests, including the elevated plus maze test, open field test, light-dark test, actophotometer, and holeboard test, were used to assess anxiolytic activity...
April 29, 2024: Scientific Reports
https://read.qxmd.com/read/38669362/the-influence-of-comt-and-abcb1-gene-polymorphisms-on-sufentanil-analgesic-effect-for-postoperative-pain-in-children-with-fracture
#4
JOURNAL ARTICLE
Hui Wang, Jianzhong An, Shan Zhong, Shigang Qiao, Li Zhang, Longde Zhao, Chen Wang
The aim of this observational study was to investigate the effects of catechol-O-methyltransferase (COMT) and ATP-binding cassette transporter B1 (ABCB1) gene polymorphisms on the postoperative analgesic effect of sufentanil in Chinese Han pediatric patients with fractures. A total of 185 pediatric patients who underwent fracture surgery were included. Polymerase chain reaction-restriction fragment length polymorphism was used to detect the polymorphisms of COMT and ABCB1 genes. Sufentanil was used for postoperative analgesia...
April 26, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38647198/rescuing-a-troubled-tolcapone-with-pegylated-plga-nanoparticles-design-characterization-and-hepatotoxicity-evaluation
#5
JOURNAL ARTICLE
Miguel Pinto, Cláudia Sofia Machado, Sandra Barreiro, Francisco J Otero-Espinar, Fernando Remião, Fernanda Borges, Carlos Fernandes
Tolcapone is an orally active catechol-O-methyltransferase (COMT) inhibitor used as adjuvant therapy in Parkinson's disease. However, it has a highly hepatotoxic profile, as recognized by the U.S. Food and Drug Administration. As a possible solution, nanoscience brought us several tools in the development of new functional nanomaterials with tunable physicochemical properties, which can be part of a solution to solve several drawbacks, including drug's short half-life and toxicity. This work aims to use PEGylated poly(lactic- co -glycolic acid) (PLGA) nanoparticles as a stable carrier with lower hydrodynamic size and polydispersity to encapsulate tolcapone in order to overcome its therapeutic drawbacks...
April 22, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38639730/bioactive-components-and-mechanisms-of-pu-erh-tea-in-improving-levodopa-metabolism-in-rats-through-comt-inhibition
#6
JOURNAL ARTICLE
Ziqiong Zhou, Yan Li, Fangyuan Wang, Guanghao Zhu, Shenglan Qi, Haonan Wang, Yuhe Ma, Rong Zhu, Yuejuan Zheng, Guangbo Ge, Ping Wang
Catechol- O -methyltransferase (COMT) plays a central role in the metabolic inactivation of endogenous neurotransmitters and xenobiotic drugs and hormones having catecholic structures. Its inhibitors are used in clinical practice to treat Parkinson's disease. In this study, a fluorescence-based visualization inhibitor screening method was developed to assess the inhibition activity on COMT both in vitro and in living cells. Following the screening of 94 natural products, Pu-erh tea extract exhibited the most potent inhibitory effect on COMT with an IC50 value of 0...
April 19, 2024: Food & Function
https://read.qxmd.com/read/38619184/clinical-prediction-of-opioid-use-disorder-in-chronic-pain-patients-a-cohort-retrospective-study-with-a-pharmacogenetic-approach
#7
JOURNAL ARTICLE
Mónica Escorial, Javier Muriel, Laura Agulló, Thomas Zandonai, César Margarit, Domingo Morales, Ana M Peiró
BACKGROUND: Opioids are widely used in chronic non-cancer pain (CNCP) management. However, they remain controversial due to serious risk of causing opioid use disorder (OUD). Our main aim was to develop a predictive model for future clinical translation that include pharmacogenetic markers. METHODS: An observational study was conducted in 806 pre-screened Spanish CNCP patients, under long-term use of opioids, to compare cases (with OUD, N.=137) with controls (without OUD, N...
April 12, 2024: Minerva Anestesiologica
https://read.qxmd.com/read/38600209/a-decision-support-system-based-on-recurrent-neural-networks-to-predict-medication-dosage-for-patients-with-parkinson-s-disease
#8
JOURNAL ARTICLE
Atiye Riasi, Mehdi Delrobaei, Mehri Salari
Using deep learning has demonstrated significant potential in making informed decisions based on clinical evidence. In this study, we deal with optimizing medication and quantitatively present the role of deep learning in predicting the medication dosage for patients with Parkinson's disease (PD). The proposed method is based on recurrent neural networks (RNNs) and tries to predict the dosage of five critical medication types for PD, including levodopa, dopamine agonists, monoamine oxidase-B inhibitors, catechol-O-methyltransferase inhibitors, and amantadine...
April 10, 2024: Scientific Reports
https://read.qxmd.com/read/38598615/a-mouse-model-of-chronic-primary-pain-that-integrates-clinically-relevant-genetic-vulnerability-stress-and-minor-injury
#9
JOURNAL ARTICLE
Yaomin Wang, Shin Hyung Kim, Marguerita E Klein, Jiegen Chen, Elizabeth Gu, Shad Smith, Andrey Bortsov, Gary D Slade, Xin Zhang, Andrea G Nackley
Chronic primary pain conditions (CPPCs) affect over 100 million Americans, predominantly women. They remain ineffectively treated, in large part because of a lack of valid animal models with translational relevance. Here, we characterized a CPPC mouse model that integrated clinically relevant genetic (catechol-O-methyltransferase; COMT knockdown) and environmental (stress and injury) factors. Compared with wild-type mice, Comt +/- mice undergoing repeated swim stress and molar extraction surgery intervention exhibited pronounced multisite body pain and depressive-like behavior lasting >3 months...
April 10, 2024: Science Translational Medicine
https://read.qxmd.com/read/38594812/opicapone-to-treat-early-wearing-off-in-parkinson-s-disease-patients-the-korean-adoption-trial
#10
JOURNAL ARTICLE
Jee-Young Lee, Hyeo-Il Ma, Joaquim J Ferreira, José-Francisco Rocha, Young Hee Sung, In-Uk Song, Tae-Beom Ahn, Do Young Kwon, Sang-Myung Cheon, Jong-Min Kim, Chong Sik Lee, Phil Hyu Lee, Jeong-Ho Park, Jae-Hyeok Lee, Mee Young Park, Sang Jin Kim, Jong Sam Baik, Seong-Min Choi, Hae-Won Shin, Ho-Won Lee, Suk Yun Kang, Beomseok Jeon
BACKGROUND: Increasing levodopa (L-dopa)/dopa decarboxylase inhibitor (DDCI) daily dose or adding a catechol-O-methyltransferase (COMT) inhibitor to levodopa/DDCI therapy are strategies used to manage wearing-off symptoms in Parkinson's disease (PD) patients. OBJECTIVES: To evaluate the COMT inhibitor opicapone versus an additional dose of levodopa to treat early wearing-off in PD patients. METHODS: ADOPTION was a randomized, parallel-group, open-label, Phase 4 study conducted in Korea...
April 9, 2024: Movement Disorders Clinical Practice
https://read.qxmd.com/read/38581434/pain-related-single-nucleotide-polymorphisms-association-with-lumbar-spinal-stenosis-patient-experience-and-non-surgical-treatment-outcomes
#11
JOURNAL ARTICLE
Sara Ernst, Wan Huang, Yvette Conley, Nam Vo, Michael Schneider, Gwendolyn Sowa
PURPOSE: Lumbar spinal stenosis (LSS) is common in our aging population resulting in pain and functional impairment. Recent advances in pain research have identified several single nucleotide polymorphisms (SNP) associated with inter-individual symptom and treatment response. The goal of the current study was to investigate the association of SNPs in Neuropeptide Y (NPY) and Catechol-O-methyltransferase (COMT) with pain, function, and treatment outcomes in Lumbar spinal stenosis (LSS) patients receiving non-surgical treatments...
April 6, 2024: European Spine Journal
https://read.qxmd.com/read/38561637/catechol-o-methyltransferase-and-monoamine-oxidase-b-inhibitory-activities-of-australian-bee-pollen
#12
JOURNAL ARTICLE
Chie Watanabe, Aoi Yanagihara, Ryo Miyata, Taichi Mitsui, Chihiro Honda, Daisuke Fujinami, Shigenori Kumazawa
Bee pollen is an apicultural product collected by honeybees from flower stamens and used as a functional food worldwide. In the present study, we aimed to elucidate the functions of Australian bee pollen. Australian bee pollen extracts and their main components were tested for catechol-O-methyltransferase (COMT) and monoamine oxidase B (MAOB) inhibitory activities. These enzymes are key neurotransmitters involved in Parkinson's disease and depression. Myricetin (5), tricetin (6), and luteolin (7) exhibited high COMT inhibitory activities (half maximal inhibitory concentration [IC50] = 23...
April 1, 2024: Bioscience, Biotechnology, and Biochemistry
https://read.qxmd.com/read/38544890/voltammetric-measurement-of-catechol-o-methyltransferase-inhibitor-tolcapone-in-the-pharmaceutical-form-on-the-boron-doped-diamond-electrode
#13
JOURNAL ARTICLE
Musa Kiran, Yavuz Yardim
This study presents an electroanalytical approach to measure the catechol-O-methyltransferase (COMT) inhibitor tolcapone (TOL) using a boron-doped diamond (BDD) electrode. The application of cyclic voltammetry (CV) technique revealed that TOL exhibited a distinct, diffusion-controlled, irreversible anodic peak at a potential of approximately +0.71 V (vs. Ag/AgCl) in a 0.1 mol L-1 phosphate buffer solution (PBS) with a pH of 2.5. The oxidation of TOL is highly dependent on the pH and supporting electrolytes...
2024: Turkish Journal of Chemistry
https://read.qxmd.com/read/38540358/the-influence-of-genetic-polymorphic-variability-of-the-catechol-o-methyltransferase-gene-in-a-group-of-patients-with-a-diagnosis-of-behavioural-addiction-including-personality-traits
#14
JOURNAL ARTICLE
Remigiusz Recław, Krzysztof Chmielowiec, Aleksandra Suchanecka, Agnieszka Boroń, Jolanta Chmielowiec, Aleksandra Strońska-Pluta, Michał Tomasz Kowalski, Jolanta Masiak, Grzegorz Trybek, Anna Grzywacz
Gambling Disorder (GD) is characterised by a harmful, enduring, and recurrent involvement in betting-related behaviours. Therefore, GD shares similar biological mechanisms and symptoms to substance use disorders (SUD). Therefore, in this study, we chose the behavioural addictions group. During the examination and recruitment to the study, it turned out that all the people undergoing treatment for gambling addiction were also addicted to amphetamines, which is consistent with the biological mechanism related to cerebral neurotransmission...
February 26, 2024: Genes
https://read.qxmd.com/read/38534761/genetic-signatures-for-distinguishing-chemo-sensitive-from-chemo-resistant-responders-in-prostate-cancer-patients
#15
JOURNAL ARTICLE
Lemohang Gumenku, Mamello Sekhoacha, Beynon Abrahams, Samson Mashele, Aubrey Shoko, Ochuko L Erukainure
Prostate cancer remains a significant public health concern in sub-Saharan Africa, particularly impacting South Africa with high mortality rates. Despite many years of extensive research and significant financial expenditure, there has yet to be a definitive solution to prostate cancer. It is not just individuals who vary in their response to treatment, but even different nodules within the same tumor exhibit unique transcriptome patterns. These distinctions extend beyond mere differences in gene expression levels to encompass the control and networking of individual genes...
March 11, 2024: Current Issues in Molecular Biology
https://read.qxmd.com/read/38532008/sex-dimorphism-controls-dysbindin-related-cognitive-dysfunctions-in-mice-and-humans-with-the-contribution-of-comt
#16
JOURNAL ARTICLE
Federica Geraci, Roberta Passiatore, Nora Penzel, Samuele Laudani, Alessandro Bertolino, Giuseppe Blasi, Adriana C E Graziano, Gianluca C Kikidis, Ciro Mazza, Madhur Parihar, Antonio Rampino, Leonardo Sportelli, Nicolò Trevisan, Filippo Drago, Francesco Papaleo, Fabio Sambataro, Giulio Pergola, Gian Marco Leggio
Cognitive dysfunctions are core-enduring symptoms of schizophrenia, with important sex-related differences. Genetic variants of the DTBPN1 gene associated with reduced dysbindin-1 protein (Dys) expression negatively impact cognitive functions in schizophrenia through a functional epistatic interaction with Catechol-O-methyltransferase (COMT). Dys is involved in the trafficking of dopaminergic receptors, crucial for prefrontal cortex (PFC) signaling regulation. Moreover, dopamine signaling is modulated by estrogens via inhibition of COMT expression...
March 26, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38508741/spasmolytic-effect-of-flopropione-does-not-involve-catechol-o-methyltransferase-comt-inhibition
#17
JOURNAL ARTICLE
Yoko Amagase, Mari Hoshiyama, Shiho Hasegawa, Miwa Kanbara, Yumiko Mizukawa, Tetsuro Urushidani
Flopropione (Flo) has been used for gallstone and urolithiasis as a spasmolytic agent almost exclusively in Japan. According to the package insert, its main mechanism is catechol-O-methyltransferase (COMT) inhibition and anti-serotonergic effect. This is obviously contrary to pharmacological common sense, but it is described that way in pharmacology textbooks and occurs in questions in the National Examination for Pharmacists in Japan. As this is a serious problem in education, we re-examined the action of Flo...
2024: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/38481699/structure-based-identification-of-kelch-like-ech-associated-protein-1-as-a-pharmacological-target-of-electrophile-containing-catechol-o-methyltransferase-inhibitors
#18
JOURNAL ARTICLE
Ping Wang, Yang Li, Jinyi Yang, Ziwen Li, Xintong Ren, Qingshi Meng, Pengfei Li, Luzhe Qin, Wei Li, Yuting Xie, Nannan Hou, Niu Huang
Entacapone and nitecapone are electrophile-containing catechol- O -methyltransferase (COMT) inhibitors that are used to treat Parkinson's disease in combination with L-DOPA. It is desirable to investigate whether they can covalently bind to cellular protein targets using their reactive electrophilic warheads. We identified Kelch-like ECH-associated protein 1 (KEAP1), a sensor for oxidative and electrophilic stress, as a potential pharmacological target of both drugs by performing covalent-based reverse docking...
March 8, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38460175/levodopa-carbidopa-entacapone-intestinal-gel-in-advanced-parkinson-disease-a-multicenter-real-life-experience
#19
JOURNAL ARTICLE
József Attila Szász, Adriana Octaviana Dulamea, Viorelia Adelina Constantin, Dafin Fior Mureşanu, Lăcrămioara Perju Dumbravă, Cristina Tiu, Dragoş Cătălin Jianu, Mihaela Simu, Amalia Ene, Any Axelerad, Cristian Falup-Pecurariu, Mihaela Lungu, Adina Gabriela Danci, Monica Sabau, Ştefan Strilciuc, Bogdan Ovidiu Popescu
BACKGROUND: For Parkinson disease (PD) patients who have been diagnosed with advanced disease that can no longer be effectively controlled with optimized oral or transdermal medications, a range of device-aided therapies (DAT) are available, comprising either deep brain stimulation or infusion therapies providing continuous dopaminergic stimulation. Levodopa-entacapone-carbidopa intestinal gel (LECIG) infusion is the latest DAT for advanced PD (APD) that was approved in Romania in 2021...
March 8, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38431413/inhibition-of-catechol-o-methyltransferase-comt-by-heparin-oligosaccharides-with-specific-structures
#20
JOURNAL ARTICLE
Qingqing Chen, Qingchi Wang, Changkai Bu, Zizhe An, Lan Jin, Lianli Chi
COMT inhibitors are commonly used to improve the effectiveness of levodopa in treating Parkinson's disease by inhibiting its conversion to 3-O-methyldopa. Because of the serious side effect of nitrocatechol COMT inhibitors, it is necessary to develop non-nitrocatechol COMT inhibitors with a higher safety profile. Heparin has been observed to bind to COMT. However, the exact functional significance of this interaction is not fully understood. In this study, the contribution of different substitution of heparin to its binding with COMT was investigated...
May 15, 2024: Carbohydrate Polymers
keyword
keyword
76985
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.